Validated HPTLC method of salmeterol xinafoate determination in inhaled pharmaceutical product and spiked human urine

Journal of Planar Chromatography - Modern TLC

Volumn 24, Issue 5, 2011, Pages 423-427

  Ahmed, Hanan A ^a   Youssef, Nadia F ^a  

^a NATIONAL ORGANIZATION FOR DRUG CONTROL AND RESEARCH NODCAR   (Egypt)

Author keywords

HPTLC; Inhaler; Spiked human urine; Validation

Indexed keywords

ACCURACY AND PRECISION; CALIBRATION CURVES; CONTROL ANALYSIS; DRUG SUBSTANCES; FLUORESCENCE QUENCHING; GOOD CORRELATIONS; HPTLC; HUMAN URINE; INHALER; LIMITS OF DETECTION; LINEARITY RANGE; MOBILE PHASE; PHARMACEUTICAL DOSAGE FORMS; PHARMACEUTICAL PRODUCTS; REFLECTION-ABSORPTION; SALMETEROL; SIMULTANEOUS IDENTIFICATION; THIN LAYERS; VALIDATION; VALIDATION METHODS;

BODY FLUIDS; DRUG DOSAGE; FLUORESCENCE; METHANOL; QUALITY CONTROL; SILICA; SILICA GEL;

DRUG PRODUCTS;

ACETIC ACID ETHYL ESTER; AMMONIA; METHANOL; SALMETEROL; SALMETEROL XINAFOATE; SILICA GEL;

ACCURACY; ADSORPTION; ARTICLE; CALIBRATION; CHILD; DENSITOMETRY; DRUG DETERMINATION; DRUG EXCRETION; DRUG STRUCTURE; FEMALE; FLUORESCENCE; HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY; HUMAN; LIMIT OF DETECTION; LIMIT OF QUANTITATION; NORMAL HUMAN; QUALITY CONTROL; QUANTITATIVE ANALYSIS; SCHOOL CHILD; SPECTRODENSITOMETRY; URINE;

EID: 80054922693     PISSN: 09334173     EISSN: 17890993     Source Type: Journal    
DOI: 10.1556/JPC.24.2011.5.11     Document Type: Article

References (15)

1. L.L. Brunton, J.S. Lazo, K.L. Parker, Goodman & Gilman's, 11th edn., McGraw-Hill, New York, 2006, pp. 717, 720-728.
2. S.C. Sweetman, Martindale: The Complete Drug Reference, 36th edn., The Pharmaceutical Press, London, 2009, p. 1135.1.
3. British Pharmacopoeia, Her Majesty's Stationary Office, London, 2009, p. 1812.
4. M. Zhang, J.P. Fawcett, J.P. Shaw, J. Chromatogr. B 729 (1999) 225-230.
5. A.F. Lehner, C.G. Hughes, W. Karpiesiuk, F.C. Camargo, J.D. Harkins, W.E. Woods, J. Bosken, J. Boyles, A. Troppmann, T. Tobin, Chromatographia 59 (2004) S79-S84.
6. V.G. Nayak, S.G. Belapure, C.D. Gaitonde, A.A. Sule, J. Pharm. Biomed. Anal. 14 (1996) 511-513.
7. A.S. Chilton, R.E. Godward, P.F. Carey, J. Pharm. Biomed. Anal. 13 (1995) 165-169.
8. N.P. Sadler, H. Jacob, Talanta 42 (1995) 1385-1388.
9. M.N. Reddy, K.V. Rao-kanna, S.S. Rao, M.E.B. Rao, Indian Drugs 37 (2000) 105-107 through A. A. CD. Supplied by WHO (2006).
10. C. Vannecke, E. Van-Gyseghem, M.S. Bloomfield, T. Coomber, Y. Vander Heyden, D.L. Massart, Anal. Chim. Acta 446 (2001) 413-428.
11. K. Assi, B.J. Clark, K.D. Altria, Pharm. Sci. 3 (1997) 593-596.
12. A.C. Moffat, D. Osselton, B. Widdop, Clark's Analysis of Drugs and Poisons, 3rd edn., The Pharmaceutical Press, London, 2004, p. 1550.
13. The United States Pharmacopoeia (32), National Formulary (27) Asian Edition, 2009, 733.
14. A.R. Gennaro, The Remington: The Science and Practice of Pharmacy, 21st edn., Lippincott Williams and Wilkins, Philadelphia, 2001, p. 138.
15. R.S. Murray, J.S. Larry, Theory and Problems of Statistics, 3rd edn., McGraw-Hill, New York, 1999, p. 525.